isovitexin has been researched along with sevoflurane in 1 studies
| Studies (isovitexin) | Trials (isovitexin) | Recent Studies (post-2010) (isovitexin) | Studies (sevoflurane) | Trials (sevoflurane) | Recent Studies (post-2010) (sevoflurane) |
|---|---|---|---|---|---|
| 123 | 0 | 81 | 7,131 | 2,150 | 3,238 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Guo, Y; Sun, L; Wu, B | 1 |
1 other study(ies) available for isovitexin and sevoflurane
| Article | Year |
|---|---|
Isovitexin restores sevoflurane‑induced cognitive dysfunction by mediating autophagy through activation of the PGC‑1α/FNDC5 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Apoptosis; Autophagy; Cognitive Dysfunction; Fibronectins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Sevoflurane; Signal Transduction | 2022 |